168 related articles for article (PubMed ID: 19153595)
21. DOK3 is required for IFN-β production by enabling TRAF3/TBK1 complex formation and IRF3 activation.
Kim SS; Lee KG; Chin CS; Ng SK; Pereira NA; Xu S; Lam KP
J Immunol; 2014 Jul; 193(2):840-8. PubMed ID: 24929003
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory effects of benzenediamine derivate FC-98 on sepsis injury in mice via suppression of JNK, NF-κB and IRF3 signaling pathways.
Song Y; Liu X; Yue H; Ji J; Dou H; Hou Y
Mol Immunol; 2015 Oct; 67(2 Pt B):183-92. PubMed ID: 26032013
[TBL] [Abstract][Full Text] [Related]
23. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
24. Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells.
Park MK; Lee HJ; Shin J; Noh M; Kim SY; Lee CH
Biochim Biophys Acta; 2011 Dec; 1811(12):1021-9. PubMed ID: 21840417
[TBL] [Abstract][Full Text] [Related]
25. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection.
Perry AK; Chow EK; Goodnough JB; Yeh WC; Cheng G
J Exp Med; 2004 Jun; 199(12):1651-8. PubMed ID: 15210743
[TBL] [Abstract][Full Text] [Related]
26. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
27. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation.
Clark K; Plater L; Peggie M; Cohen P
J Biol Chem; 2009 May; 284(21):14136-46. PubMed ID: 19307177
[TBL] [Abstract][Full Text] [Related]
28. Involvement of SAPK/JNK in prostaglandin E(1)-induced VEGF synthesis in osteoblast-like cells.
Kanno Y; Tokuda H; Nakajima K; Ishisaki A; Shibata T; Numata O; Kozawa O
Mol Cell Endocrinol; 2004 May; 220(1-2):89-95. PubMed ID: 15196703
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of DDX3 expression by ginsenoside Rg3 through the Akt/p53 pathway activates the innate immune response via TBK1/IKKε/IRF3 signalling.
Choi YJ; Kang LJ; Lee SG
Curr Med Chem; 2014; 21(8):1050-60. PubMed ID: 24180280
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization, expression of chicken TBK1 gene and its effect on IRF3 signaling pathway.
Wang Y; Yin Y; Lan X; Ye F; Tian K; Zhao X; Yin H; Li D; Xu H; Liu Y; Zhu Q
PLoS One; 2017; 12(5):e0177608. PubMed ID: 28493975
[TBL] [Abstract][Full Text] [Related]
31. A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos inhibits the production of inflammatory mediators and the IRAK-1/TAK1 and TBK1/IRF3 pathways in RAW 264.7 and THP-1 cells.
Cheng BC; Yu H; Su T; Fu XQ; Guo H; Li T; Cao HH; Tse AK; Kwan HY; Yu ZL
J Ethnopharmacol; 2015 Nov; 174():195-9. PubMed ID: 26297845
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
33. Complex Regulation Pattern of IRF3 Activation Revealed by a Novel Dimerization Reporter System.
Wang Z; Ji J; Peng D; Ma F; Cheng G; Qin FX
J Immunol; 2016 May; 196(10):4322-30. PubMed ID: 27045107
[TBL] [Abstract][Full Text] [Related]
34. Nonparticipation of nuclear factor kappa B (NFkappaB) in the signaling cascade of c-Jun N-terminal kinase (JNK)- and p38 mitogen-activated protein kinase (p38MAPK)-dependent tumor necrosis factor alpha (TNFalpha) induction in lipopolysaccharide (LPS)-stimulated microglia.
Uesugi M; Nakajima K; Tohyama Y; Kohsaka S; Kurihara T
Brain Res; 2006 Feb; 1073-1074():48-59. PubMed ID: 16457791
[TBL] [Abstract][Full Text] [Related]
35. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
[TBL] [Abstract][Full Text] [Related]
36. Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways.
Suzuki S; Zhou Y; Refaat A; Takasaki I; Koizumi K; Yamaoka S; Tabuchi Y; Saiki I; Sakurai H
J Biol Chem; 2010 Feb; 285(7):4441-6. PubMed ID: 19955181
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of JDP2 on threonine-148 by the c-Jun N-terminal kinase targets it for proteosomal degradation.
Weidenfeld-Baranboim K; Koren L; Aronheim A
Biochem J; 2011 Jun; 436(3):661-9. PubMed ID: 21463260
[TBL] [Abstract][Full Text] [Related]
38. Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase.
Korhonen R; Linker K; Pautz A; Förstermann U; Moilanen E; Kleinert H
Mol Pharmacol; 2007 May; 71(5):1427-34. PubMed ID: 17322004
[TBL] [Abstract][Full Text] [Related]
39. Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophages.
Solis M; Romieu-Mourez R; Goubau D; Grandvaux N; Mesplede T; Julkunen I; Nardin A; Salcedo M; Hiscott J
Eur J Immunol; 2007 Feb; 37(2):528-39. PubMed ID: 17236232
[TBL] [Abstract][Full Text] [Related]
40. IKK-i signals through IRF3 and NFkappaB to mediate the production of inflammatory cytokines.
Sankar S; Chan H; Romanow WJ; Li J; Bates RJ
Cell Signal; 2006 Jul; 18(7):982-93. PubMed ID: 16199137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
